Glaucoma Trial, Recruiting NCT06865235 Sponsor: Faculdade de Ciências Médicas de Minas Gerais Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT06865235
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 40 years old or older
  • You are already a patient in the glaucoma department at one of the hospitals taking part in this study
  • You need cataract surgery, confirmed by an eye exam showing your vision is 20/40 or worse
  • You have been diagnosed with Primary Open Angle Glaucoma (POAG), a specific type of glaucoma identified by certain changes to your vision and the appearance of your optic nerve
  • The drainage angle in your eye meets certain measurements seen during a special eye examination called gonioscopy (confirm with trial site)
  • Your eye pressure is 25 mmHg or below while using your current eye pressure-lowering drops
  • Your eye pressure rises to between 22 and 30 mmHg when your eye drops are temporarily stopped, or your medical records show your eye pressure has been 21 mmHg or higher on more than one previous visit

Who may not be able to join:

  • You have severe glaucoma, as measured by a specific medical grading system (confirm with trial site)
  • The length of your eye is either larger than 26 mm or smaller than 21 mm
  • The number of protective cells on the inner surface of your eye is below a certain level (confirm with trial site)
  • The thickness of your cornea (the clear front part of your eye) falls outside an acceptable range (confirm with trial site)
  • You have had, or are due to have, any other eye surgery or laser treatment around the time of this study
  • You experience a serious unexpected problem during surgery while taking part in the study
  • Your eye pressure remains very high even when using many different eye pressure-lowering medications, suggesting your glaucoma is progressing rapidly

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +5531991055860

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Faculdade de Ciências Médicas de Minas Gerais
Registry
ClinicalTrials.gov
Start date
7 May 2024
Est. completion
1 February 2028

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Change in intraocular pressure (IOP) after surgery.; Change in the number of glaucoma medications after surgery.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov